Splenectomy for the treatment of hairy-cell leukemia

S. Eldar, M. M. Kemeny, J. R. Benfield

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


In conclusion, patients with hairy-cell leukemia may need no therapy for prolonged periods. If they are symptomatic from hypersplenism, they may be expected to benefit from splenectomy. Some patients will have a relapse after splenectomy. At this time, there is no method to predict which patients will have a long term benefit from splenectomy, and we believe that operation should not be recommended as the primary therapy for hairy-cell leukemia.

Original languageEnglish
Pages (from-to)829-832
Number of pages4
JournalSurgery Gynecology and Obstetrics
Issue number6
StatePublished - 1982
Externally publishedYes


Dive into the research topics of 'Splenectomy for the treatment of hairy-cell leukemia'. Together they form a unique fingerprint.

Cite this